Showing 8731-8740 of 19239 results for "".
- Unlocking New Pathways: Cabergoline’s Role in Diabetes Managementhttps://reachmd.com/news/unlocking-new-pathways-cabergolines-role-in-diabetes-management/2482990/Central to the scientific interest in cabergoline is the hypothesis that it may influence glucose control via dopamine D2-like receptor agonism, a concept supported by preliminary evidence discussed in a mechanistic review. Building on that framework,
- Linking Retinal Nonperfusion to Sensitivity Loss: New Insights for Diabetic Retinopathyhttps://reachmd.com/news/retinal-nonperfusion-sensitivity-loss-diabetic-retinopathy/2485332/A UK longitudinal cohort linked retinal capillary nonperfusion on ultra-widefield angiography to localized declines in retinal sensitivity on automated perimetry, s
- Innovations in AI: Transforming Diabetic Eye Care at The People's Health Clinichttps://reachmd.com/news/ai-diabetic-eye-care-peoples-health-clinic/2484529/The People's Health Clinic has deployed LumineticsCore
- Surprising Patterns in Infant Growth After Gestational Diabetes Exposurehttps://reachmd.com/news/surprising-patterns-in-infant-growth-after-gestational-diabetes-exposure/2468668/
- Sitting Time May Increase Risk of All-Cause Mortality in Adults with Diabeteshttps://reachmd.com/news/sitting-time-may-increase-risk-of-all-cause-mortality-in-adults-with-diabetes/2467725/
- DNA Sequencing Enhances Non-Invasive Early Detection of Gestational Diabeteshttps://reachmd.com/news/dna-sequencing-enhances-non-invasive-early-detection-of-gestational-diabetes/2457033/
- Cardiovascular and Safety Signals After GLP‑1 Discontinuation: Register Evidencehttps://reachmd.com/news/cardiovascular-and-safety-signals-after-glp1-discontinuation-register-evidence/2486323/A large register-based analysis of U.S. veterans with type 2 diabetes reported that stopping or interrupting GLP-1 receptor agonist therapy was associated with higher rates of major adver
- Navigating the Pathways of Glucose to Enhance Metabolic Healthhttps://reachmd.com/news/navigating-the-pathways-of-glucose-to-enhance-metabolic-health/2483007/Glucose transporters continue to influence the regulation of insulin secretion and broader metabolic processes. Their relevance in managing type 2 Diabetes and endocrine disorders is well-established. The mechanism of glucose transporters involves isoforms such as GLUT2 and GLUT4 fac
- Merging Nutritional and Molecular Strategies in Metabolic Disorder Managementhttps://reachmd.com/news/merging-nutritional-and-molecular-strategies-in-metabolic-disorder-management/2475157/Clinicians are witnessing the convergence of molecular tracers and nutritional science to tackle the complexities of metabolic disorders, with glucagon isotopes illuminating elusive pancreatic alpha cell behavior in Type 1 diabetes, while nat
- Revolutionizing Chronic Disease Management Through Telemedicine and Physical Activityhttps://reachmd.com/news/revolutionizing-chronic-disease-management-through-telemedicine-and-physical-activity/2471231/The integration of telemedicine and strategic physical activity is transforming how chronic diseases, particularly type 2 diabetes, are managed, offering improved patient outcomes and innovative healthcare solutions. Telemedicine's Role in Chro